132 related articles for article (PubMed ID: 34979099)
1. Identification of proteomic changes for dexamethasone-induced ocular hypertension using a tandem mass tag (TMT) approach.
Liang X; Li N; Rong Y; Wang J; Zhang H
Exp Eye Res; 2022 Mar; 216():108914. PubMed ID: 34979099
[TBL] [Abstract][Full Text] [Related]
2. Proteomic analysis of the trabecular meshwork of rats in a steroid-induced ocular hypertension model: downregulation of type I collagen C-propeptides.
Shinzato M; Yamashiro Y; Miyara N; Iwamatsu A; Takeuchi K; Umikawa M; Bayarjargal M; Kariya K; Sawaguchi S
Ophthalmic Res; 2007; 39(6):330-7. PubMed ID: 18046086
[TBL] [Abstract][Full Text] [Related]
3. Perfusion-cultured bovine anterior segments as an ex vivo model for studying glucocorticoid-induced ocular hypertension and glaucoma.
Mao W; Tovar-Vidales T; Yorio T; Wordinger RJ; Clark AF
Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8068-75. PubMed ID: 21911581
[TBL] [Abstract][Full Text] [Related]
4. Dexamethasone-Induced Ocular Hypertension in Mice: Effects of Myocilin and Route of Administration.
Patel GC; Phan TN; Maddineni P; Kasetti RB; Millar JC; Clark AF; Zode GS
Am J Pathol; 2017 Apr; 187(4):713-723. PubMed ID: 28167045
[TBL] [Abstract][Full Text] [Related]
5. Mitochondria and Autophagy Dysfunction in Glucocorticoid-Induced Ocular Hypertension/Glaucoma Mice Model.
Zeng W; Wang W; Wu S; Zhu X; Zheng T; Chen X; Ren J; Gong Y; Ke M
Curr Eye Res; 2020 Feb; 45(2):190-198. PubMed ID: 31425668
[No Abstract] [Full Text] [Related]
6. Effect of topical Ginkgo biloba extract on steroid-induced changes in the trabecular meshwork and intraocular pressure.
Jia LY; Sun L; Fan DS; Lam DS; Pang CP; Yam GH
Arch Ophthalmol; 2008 Dec; 126(12):1700-6. PubMed ID: 19064852
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid induction of the glaucoma gene MYOC in human and monkey trabecular meshwork cells and tissues.
Clark AF; Steely HT; Dickerson JE; English-Wright S; Stropki K; McCartney MD; Jacobson N; Shepard AR; Clark JI; Matsushima H; Peskind ER; Leverenz JB; Wilkinson CW; Swiderski RE; Fingert JH; Sheffield VC; Stone EM
Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1769-80. PubMed ID: 11431441
[TBL] [Abstract][Full Text] [Related]
8. Proteomic analysis of rat retina in a steroid-induced ocular hypertension model: potential vulnerability to oxidative stress.
Miyara N; Shinzato M; Yamashiro Y; Iwamatsu A; Kariya KI; Sawaguchi S
Jpn J Ophthalmol; 2008; 52(2):84-90. PubMed ID: 18626730
[TBL] [Abstract][Full Text] [Related]
9. Ultrastructural changes associated with dexamethasone-induced ocular hypertension in mice.
Overby DR; Bertrand J; Tektas OY; Boussommier-Calleja A; Schicht M; Ethier CR; Woodward DF; Stamer WD; Lütjen-Drecoll E
Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):4922-33. PubMed ID: 25028360
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoid Receptor Transactivation Is Required for Glucocorticoid-Induced Ocular Hypertension and Glaucoma.
Patel GC; Millar JC; Clark AF
Invest Ophthalmol Vis Sci; 2019 May; 60(6):1967-1978. PubMed ID: 31050723
[TBL] [Abstract][Full Text] [Related]
11. Myocilin gene expression in the trabecular meshwork of rats in a steroid-induced ocular hypertension model.
Sawaguchi K; Nakamura Y; Nakamura Y; Sakai H; Sawaguchi S
Ophthalmic Res; 2005; 37(5):235-42. PubMed ID: 16020952
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoid receptor GRβ regulates glucocorticoid-induced ocular hypertension in mice.
Patel GC; Liu Y; Millar JC; Clark AF
Sci Rep; 2018 Jan; 8(1):862. PubMed ID: 29339763
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor β2 (TGFβ2) signaling plays a key role in glucocorticoid-induced ocular hypertension.
Kasetti RB; Maddineni P; Patel PD; Searby C; Sheffield VC; Zode GS
J Biol Chem; 2018 Jun; 293(25):9854-9868. PubMed ID: 29743238
[TBL] [Abstract][Full Text] [Related]
14. Expression of 14-3-3 Zeta Protein in Dexamethasone-Treated Mice and Human TM-1 Cells.
Liu Q; Ye Y; Lin X; Yang Y; Wu K; Yu M
Curr Eye Res; 2017 Aug; 42(8):1124-1129. PubMed ID: 28494163
[TBL] [Abstract][Full Text] [Related]
15. Protein expression in human trabecular meshwork: downregulation of RhoGDI by dexamethasone in vitro.
Yu M; Sun J; Peng W; Chen Z; Lin X; Liu X; Li M; Wu K
Mol Vis; 2010 Feb; 16():213-23. PubMed ID: 20161819
[TBL] [Abstract][Full Text] [Related]
16. Incidence, Risk Factors, Treatment, and Outcome of Ocular Hypertension following Intravitreal Steroid Injections: A Comparative Study.
Badrinarayanan L; Rishi P; George R; Isaac N; Rishi E;
Ophthalmologica; 2022; 245(5):431-438. PubMed ID: 35468616
[TBL] [Abstract][Full Text] [Related]
17. Ocular Hypertension Following Intravitreal Injection of 0.7mg Dexamethasone Implant versus 2mg Triamcinolone.
Kuley B; Storey PP; Pancholy M; Obeid A; Murphy J; Goodman J; Wibbelsman TD; Regillo C; Chiang A
Semin Ophthalmol; 2020 Feb; 35(2):141-146. PubMed ID: 32343619
[No Abstract] [Full Text] [Related]
18. A rabbit model of age-dependant ocular hypertensive response to topical corticosteroids.
Qin Y; Lam S; Yam GH; Choy KW; Liu DT; Chiu TY; Li WY; Lam DS; Pang CP; Fan DS
Acta Ophthalmol; 2012 Sep; 90(6):559-63. PubMed ID: 21044276
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the myocilin (MYOC) glaucoma gene in monkey and human steroid-induced ocular hypertension.
Fingert JH; Clark AF; Craig JE; Alward WL; Snibson GR; McLaughlin M; Tuttle L; Mackey DA; Sheffield VC; Stone EM
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):145-52. PubMed ID: 11133859
[TBL] [Abstract][Full Text] [Related]
20. Proteomic similarities in steroid responsiveness in normal and glaucomatous trabecular meshwork cells.
Bollinger KE; Crabb JS; Yuan X; Putliwala T; Clark AF; Crabb JW
Mol Vis; 2012; 18():2001-11. PubMed ID: 22876128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
